Represented MAIA Biotechnology, Inc. a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, in a $4.6 million public offering.
-
-
资深顾问律师
It looks like we may have content for your preferred language. Would you like to view this page in English?
Represented MAIA Biotechnology, Inc. a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, in a $4.6 million public offering.